4,5-dichlorobenzene-1,3-disulfonamide-13C6; 1,3-Disulfamoyl-4,5-dichlorobenzene-13C6; 1,3-Disulfamyl-4,5-dichlorobenzene-13C6; 3,4-Dichloro-5-sulfamylbenzenesulfonamide-13C6; 4,5-Dichloro-1,3-disulfamoylbenzene-13C6; 4,5-Dichloro-m-benzenedisulfonamide-13C6; Antidrasi-13C6; CB 8000-13C6; Daramide-13C6; Daranide-13C6; Dichlofenamide-13C6; Dichlorophenamide-13C6; Dichlorphenamide-13C6; Diclofenamid-13C6; Glaucol-13C6; Oratrol-13C6
Dichlorphenamide-13C6 (Diclofenamide-13C6) is a fully characterized chemical compound used as a reference standard of API Dichlorphenamide. The standard offered is compliant with regulatory guidelines. Dichlorphenamide-13C6 (Diclofenamide-13C6) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1391054-76-4
